BioRender 아이콘

Child 4 (gender-neutral, stage I obesity, anterior)

Child 4 (gender-neutral, stage I obesity, anterior) - Editable icon of a gender-neutral child with stage I obesity with stage I obesity in an anterior anatomical position with South Asian facial features
[{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f08fc/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f08fc/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f08fd/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f08fd/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f08fe/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f08fe/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f08ff/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f08ff/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0900/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0900/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0901/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0901/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0902/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0902/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0903/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0903/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0904/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0904/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0905/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0905/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0906/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0906/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0907/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0907/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0908/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0908/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0909/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0909/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090a/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090a/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090b/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090b/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090c/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090c/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090d/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090d/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090e/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090e/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090f/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090f/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0910/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0910/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0911/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0911/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0912/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0912/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0913/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0913/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0914/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0914/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0915/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0915/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0916/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0916/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0917/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0917/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0918/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0918/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0919/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0919/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f091a/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f091a/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f091b/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f091b/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f091c/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f091c/671a99891adafe9ee12f08bc.png"}]
이 아이콘 사용하기 – 무료
가입 시 신용카드가 필요하지 않습니다.

이 아이콘은 BioRender에서 자유롭게 편집할 수 있습니다

  • 텍스트, 도형 및 기타 아이콘 추가
  • 5만 개 이상의 과학적으로 정확한 아이콘을 검색하세요
  • 모든 아이콘, 선, 라벨의 색상과 배치를 자유롭게 변경하세요
  • 어떤 용도로든 내보내거나 공유하세요
Scientist Avatars

이미 출판용 수준의 그림을 만들고 있는 400만 명 이상의 과학자들과 함께하세요

아이콘으로 몇 분 만에 완성된 그림을 만들어 보세요

  • 검색 50,000개 이상의 과학적으로 정확하고 동료 검토를 거친 아이콘 제공
  • 맞춤 설정 라벨, 도형, 추가 아이콘을 사용하여 모든 요소를 자유롭게 편집할 수 있습니다.
  • 내보내기 또는 공동 작업자와 그림 공유하기
    ‍
page dashboard

찾으시는 아이콘이 아닌가요? 더 많은 아이콘을 확인해 보세요.

30개 이상의 생명과학 분야에 걸친 50,000개 이상의 아이콘을 검색하세요.

search icon
arrow-right
child,gender-neutral child,child gender neutral,gender-neutral,neutral,asexual,unsexed,sexless,male child,female child,boy child,girl child,boy,girl,young,young age,small child,children,kid,human child,minor,adolescent,preadolescence,preteen,preteenager,tween,tweenager,tweener,overweight,obese,obesity stage I,high BMI,excess weight,large,chubby,plus-sized,heavy,full-figured,above average weight,back,head,limbs,arm,leg,hand,foot,feet,anterior,frontal,front view,anterior view,front,nude,naked,without clothes,unclothed,human,human figure,figure,child development,development,puberty,pediatric,pediatrics,whole body,body,age,person,human anatomy,anatomy,South Asian,brown-skinned,dark skinned,dark complexion,brown,Indian,Pakistani,Bangladeshi,Desi,Indo,South Asian Diaspora,Sri Lankan,Nepalese,Bhutanese,Tamil,24q2-content-refinement,24q2-content-refinement-human-figure-diversity,child
더 보기

동의어를 검색하거나 가입하여 앱에서 아이콘을 요청해 보세요.

이미지 유형

Child 4 (gender-neutral, stage I obesity, anterior) icon JPEG

Child 4 (gender-neutral, stage I obesity, anterior) icon PNG

Child 4 (gender-neutral, stage I obesity, anterior) icon SVG

Child 4 (gender-neutral, stage I obesity, anterior) icon GIF

BioRender 아이콘 FAQ

How are scientists using the Child 4 (gender-neutral, stage I obesity, anterior) icon in their work?

BioRender users often use the Child 4 (gender-neutral, stage I obesity, anterior) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Human Anatomy.

이 아이콘을 BioRender 그림이나 과학 일러스트레이션에 사용할 수 있나요?

Yes, the Child 4 (gender-neutral, stage I obesity, anterior) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Child 4 (gender-neutral, stage I obesity, anterior) icon customizable in BioRender?

Most icons in BioRender, including the Child 4 (gender-neutral, stage I obesity, anterior) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Child 4 (gender-neutral, stage I obesity, anterior) icon for publication or presentations?

Yes, figures containing the Child 4 (gender-neutral, stage I obesity, anterior) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Child 4 (gender-neutral, stage I obesity, anterior) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Child 4 (gender-neutral, stage I obesity, anterior) icon — especially those focused on Human Anatomy. You can search BioRender’s template library or add this icon manually to any canvas.

BioRender란 무엇인가요?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Child 4 (gender-neutral, stage I obesity, anterior) icon along with our library of more than 30,000 life science icons.

BioRender에서 이 아이콘 사용하기

지금 바로 전문가 수준의 과학 피규어를 만들어 보세요
antibody elements3D Phospholipid illustration

과학 콘텐츠를 찾고 계신가요?

동료 검토를 거쳐 사용하기 쉽고 무료로 제공되는 5만 개 이상의 아이콘과 템플릿을 살펴보세요.

지금 바로 찾아보세요
x icon